| 货号 | HV974276 |
|---|
| 产品名称 | Research Grade Anti-Human CD274/PD-L1/B7-H1 (CBT-502) |
|---|
| 中文品名/别名 | CBT-502, CBT502, CBT502 |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | Human |
|---|
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274 |
|---|
| 基因号 | Q9NZQ7 |
|---|
| 宿主/表达体系 | Human |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Anti-Human CD274/PD-L1/B7-H1 (CBT-502) ( HV974276 ) is a research-grade recombinant antibody targeting CD1 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|